|
RCC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.0882000018041E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98473999999393E-05 |
| Normal-vs-Stage2 |
1.399810E-01 |
| Normal-vs-Stage3 |
1.20399999969933E-07 |
| Normal-vs-Stage4 |
3.63490004762212E-09 |
| Stage1-vs-Stage2 |
1.089780E-01 |
| Stage1-vs-Stage3 |
2.506400E-02 |
| Stage1-vs-Stage4 |
6.402700E-04 |
| Stage2-vs-Stage3 |
6.998900E-03 |
| Stage2-vs-Stage4 |
2.988700E-04 |
| Stage3-vs-Stage4 |
1.807200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91369999846813E-08 |
| Normal-vs-AfricanAmerican |
4.897000E-03 |
| Normal-vs-Asian |
4.008300E-04 |
| Caucasian-vs-AfricanAmerican |
3.573000E-01 |
| Caucasian-vs-Asian |
2.154600E-01 |
| AfricanAmerican-vs-Asian |
1.090560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70219999984234E-07 |
| Normal-vs-Female |
8.7927000014254E-08 |
| Male-vs-Female |
6.410800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.983600E-04 |
| Normal-vs-Age(41-60Yrs) |
5.40279999627913E-08 |
| Normal-vs-Age(61-80Yrs) |
6.85860000015914E-07 |
| Normal-vs-Age(81-100Yrs) |
3.347400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.860600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.371850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.213900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.310600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.307900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.024590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.722600E-03 |
| Normal-vs-Grade 2 |
4.76800000004385E-06 |
| Normal-vs-Grade 3 |
2.32229999996836E-06 |
| Normal-vs-Grade 4 |
1.43180023393086E-10 |
| Grade 1-vs-Grade 2 |
6.437000E-01 |
| Grade 1-vs-Grade 3 |
8.048400E-01 |
| Grade 1-vs-Grade 4 |
1.238430E-01 |
| Grade 2-vs-Grade 3 |
6.163200E-01 |
| Grade 2-vs-Grade 4 |
4.46170000000246E-05 |
| Grade 3-vs-Grade 4 |
4.2733000000017E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.008300E-04 |
| Normal-vs-ccB subtype |
1.73590000152046E-08 |
| ccA subtype-vs-ccB subtype |
6.168800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33150000003468E-06 |
| Normal-vs-N1 |
3.76810000000116E-05 |
| N0-vs-N1 |
7.805200E-04 |
|
|
